SFS
VKTX icon

Sowell Financial Services’s Viking Therapeutics VKTX Stock Holding History

Sowell Financial Services’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,393
Closed -$8K – 2663
2021
Q1 		$8K Buy
1,393
+146
+12% +$1.03K ﹤0.01% 2425
2020
Q4 		$7K Sell
1,247
-613
-33% -$3.71K ﹤0.01% 2179
2020
Q3 		$11K Hold
1,860
– – ﹤0.01% 1791
2020
Q2 		$13K Buy
1,860
+575
+45% +$3.82K ﹤0.01% 1610
2020
Q1 		$6K Sell
1,285
-30
-2% -$184 ﹤0.01% 1789
2019
Q4 		$11K Sell
1,315
-395
-23% -$2.88K ﹤0.01% 1666
2019
Q3 		$12K Buy
+1,710
New +$12.7K ﹤0.01% 1483

Other funds holding VKTX

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sowell Financial Services's VKTX Position: Q2 2021 in Review

Sowell Financial Services sold out of Viking Therapeutics (VKTX) in Q2 2021, closing a stake of 1,393 shares — an estimated $8K sold.

Sowell Financial Services first reported a position in VKTX in Q3 2019 and held it in 7 quarters. The position peaked at $13K in Q2 2020. 138 funds tracked by Wall St. Rank hold VKTX as of Q2 2021.

  • Sowell Financial Services reported no remaining Viking Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,393 Viking Therapeutics shares in Q2 2021, an estimated $8K.
  • Sowell Financial Services first reported a position in Viking Therapeutics in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Viking Therapeutics position peaked at $13K in Q2 2020.
  • 138 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.